Commentary: Sulfoxone (Diasone) in the Treatment of Dermatitis Herpetiformis
- 1 October 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 118 (10) , 809-812
- https://doi.org/10.1001/archderm.1982.01650220113016
Abstract
From JAMA Dermatology — Commentary — Sulfoxone (Diasone) in the Treatment of Dermatitis HerpetiformisThis publication has 10 references indexed in Scilit:
- Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsoneJournal of the American Academy of Dermatology, 1982
- Dapsone and discoid lupus erythematosusBritish Journal of Dermatology, 1982
- Carcinogenicity of dapsone in mice and ratsInternational Journal of Cancer, 1980
- Sulfones and sulfonamides in dermatology todayJournal of the American Academy of Dermatology, 1979
- Inhibition of lysosomal enzymes by dapsoneBritish Journal of Dermatology, 1975
- Biochemical effects of aromatic amines-I. Methaemoglobinaemia, haemolysis and heinz-body formation induced by 4,4′-diaminodiphenylsulphoneBiochemical Pharmacology, 1965
- Treatment of Dermatitis Herpetiformis with Diamino-Diphenyl-Sulphone (D.D.S.)Dermatology, 1953
- PROMACETIN® THERAPY OF DERMATITIS HERPETIFORMISArchives of Dermatology, 1952
- SULFOXONE (DIASONE®) SODIUM FOR DERMATITIS HERPETIFORMISArchives of Dermatology, 1951
- PROGNOSIS OF DERMATITIS HERPETIFORMIS, TREATED AND UNTREATEDArchives of Dermatology, 1951